Fermenta Biotech Ltd. (FERMENTA) Share Price Within 2% of 52-Week High

Fermenta Biotech Ltd. Share Price stands at Rs 567, with the stock trading within 2% of its 52-week high. The company’s market capitalisation is Rs 1,646.81 crore.

Fermenta Biotech Ltd. Share Price was Rs 567 at the time this Univest article was triggered on 10 August 2026 at 10:30:37 AM IST, placing the stock within 2% of its 52-week high. With a market capitalisation of Rs 1,646.81 crore, the move is notable because proximity to a one-year peak often draws additional market attention to both momentum and valuation.

The supplied data confirms the price event but does not establish a company-specific catalyst. Even so, Fermenta Biotech Ltd. Share Price moving close to its yearly high matters because it puts a spotlight on how the stock is being valued relative to its industry, how profitable the business looks on the available ratios, and how it compares with similarly sized listed pharmaceutical companies.

For investors tracking Fermenta Biotech Ltd. Share Price Today, the current setup is less about speculation and more about context. Univest highlights the event as a screening signal: a stock near its 52-week high can indicate sustained investor interest, but the durability of that attention depends on earnings quality, capital efficiency, balance sheet strength, and relative valuation. That makes a combined view of price behaviour, fundamentals and industry comparison especially relevant in Fermenta Biotech Ltd. Stock News.

Fermenta Biotech Ltd. Share Price Today: Within 2% of 52-Week High

Metric	Value
LTP at 2% Qualification	Rs 567
Market Capitalisation	Rs 1,646.81 crore
52-Week High Position	Trading within 2% of its 52-week high

Fermenta Biotech Ltd. (FERMENTA) traded at Rs 567. Reported volume was 7,756.

Fermenta Biotech Ltd. Share Price Today was Rs 567 at qualification, according to the Univest screener, and the stock was identified as trading within 2% of its 52-week high. The qualification is important because it confirms that the stock is close to its one-year peak, even though the supplied dataset does not attribute the move to any specific operational or corporate trigger.

In practical market terms, a stock trading near its 52-week high often becomes more visible to short-term traders, momentum watchers and longer-term investors who use price strength as an early filter before checking balance-sheet and profitability data. Fermenta Biotech Ltd. Share Price therefore enters a part of the market conversation where technical resilience and valuation discipline both matter.

The current price also places the company in a zone where sentiment can become more sensitive to earnings quality and relative multiples. Fermenta Biotech Ltd. Share Price is not just being watched because it is elevated versus its own recent history; it is also being judged against what the Healthcare and Pharmaceuticals & Drugs universe is offering in terms of earnings multiples and return ratios.

That is why the near-52-week-high setup deserves a deeper read. When a stock sits close to its annual high, investors typically ask whether the market is rewarding stronger business quality, richer valuations, or a scarcity premium within its industry basket. The available Univest data helps frame that discussion through fundamentals, sector benchmarks and peer positioning.

Fermenta Biotech Ltd. (FERMENTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,646.81 crore
P/E Ratio	22.95x
P/B Ratio	4.08x
ROE	4.27%
ROCE	7.5%
EPS	Rs 24.38
Book Value Per Share	Rs 137.06
Dividend Yield	0.67%

Fermenta Biotech Ltd. was valued at a P/E ratio of 22.95x, a P/B ratio of 4.08x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 4.27% and ROCE of 7.5%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 24.38, book value per share of Rs 137.06, dividend yield of 0.67%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	22.95x
Benchmark Median P/E	18.11x
Benchmark Average P/E	60.26x
Benchmark P/E Range	0x to 3,417.8x
Company P/B Ratio	4.08x
Benchmark Median P/B	1.82x
Company ROE	4.27%
Benchmark Median ROE	9.93%
Company ROCE	7.5%
Benchmark Median ROCE	12.96%
Company Market Capitalisation	Rs 1,646.81 crore
Benchmark Median Market Cap	Rs 142.3 crore

Fermenta Biotech Ltd. (FERMENTA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 22.95x, which is above the benchmark median of 18.11x, a difference of +26.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Fermenta Biotech Ltd. (FERMENTA) has a ROE of 4.27%, which is below the benchmark median of 9.93%, a difference of -57%. Fermenta Biotech Ltd. (FERMENTA) has a ROCE of 7.5%, which is below the benchmark median of 12.96%, a difference of -42.13%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Jagsonpal Pharmaceuticals Ltd.	JAGSNPHARM	1,533.19	33.71	6.11	15.7	19.43
Amrutanjan Health Care Ltd.	AMRUTANJAN	1,511.88	26.1	4.08	32.69	44
Windlas Biotech Ltd.	WINDLAS	1,823.52	27.44	3.55	12.87	14.88
Ind-Swift Laboratories Ltd.	INDSWFTLAB	1,986.64	47.97	1.35	-0.78	8.31
Indoco Remedies Ltd.	INDOCO	2,045.45	363.31	2.04	12.85	15.67

Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 22.95x compared with the displayed peer median of 33.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.27% compares with a peer median of 12.87% across the companies shown in the table. ROCE stood at 7.5% versus the displayed peer median of 15.67%, providing a capital-efficiency comparison. Fermenta Biotech Ltd. (FERMENTA) has a market capitalisation of Rs 1,646.81 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Fermenta Biotech Ltd.

• Fermenta Biotech Ltd. Share Price is Rs 567 and the stock is trading within 2% of its 52-week high, a screen that often increases market attention.
• The company has a market capitalisation of Rs 1,646.81 crore, placing it well above the same-industry median size of Rs 142.3 crore.
• Its P/E of 22.95 is above the industry median of 18.11 but below the industry average of 60.26, creating a balanced valuation discussion.
• Its P/B of 4.08 is well above the same-industry median of 1.82, indicating that the market is assigning a premium to book value.
• ROE of 4.27 and ROCE of 7.5 are below industry medians of 9.93 and 12.96, making profitability a key metric to monitor.
• Compared with key peers on Univest, the stock appears more moderate on P/E than several names, but less efficient on return ratios.

About Fermenta Biotech Ltd.

Fermenta Biotech Ltd. operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry in the supplied dataset. That places the company within a segment of the market where investors typically compare valuations through earnings multiples, book-value multiples and capital-efficiency ratios rather than looking only at price momentum.

From a market-positioning standpoint, Fermenta Biotech Ltd. sits in the mid-sized listed bracket of its industry with a market capitalisation of Rs 1,646.81 crore. In the context of the same-industry benchmark used by Univest, that makes it meaningfully larger than the median listed company in the comparison universe.

Because the supplied company information is limited to sector and industry classification, the most reliable way to frame the business is through its placement in Healthcare and Pharmaceuticals & Drugs. For investors following Fermenta Biotech Ltd. Share Price, that means the stock is being assessed in a sector where relative valuation, profitability and peer positioning often shape market interest as much as headline price action.

Track Fermenta Biotech Ltd. Share Price on Univest

Use Fermenta Biotech Ltd. (FERMENTA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking Fermenta Biotech Ltd. Share Price can use Univest to follow live price moves, 52-week levels, valuation ratios, profitability metrics and broader market context in one place. For a stock trading close to its one-year high, that kind of integrated view helps separate raw price strength from the financial and sector data behind it.

Univest also helps users monitor how Fermenta Biotech Ltd. Share Price compares with Healthcare and Pharmaceuticals & Drugs benchmarks, as well as with selected listed peers on P/E, P/B, ROE, ROCE and market capitalisation. When a stock is near its 52-week high, these relative comparisons often matter more than the headline move itself.

Frequently Asked Questions

What is Fermenta Biotech Ltd. Share Price today?

Ans. Fermenta Biotech Ltd. Share Price was Rs 567 at the time of the Univest screener event on 10 August 2026 at 10:30:37 AM IST. The stock was also identified as trading within 2% of its 52-week high.

Why is Fermenta Biotech Ltd. Share Price in focus?

Ans. Fermenta Biotech Ltd. Share Price is in focus because the stock is trading within 2% of its 52-week high. That proximity often draws investor attention to valuation, profitability, peer positioning and broader sector comparisons.

What is the market capitalisation of Fermenta Biotech Ltd.?

Ans. Fermenta Biotech Ltd. has a market capitalisation of Rs 1,646.81 crore. In the supplied same-industry benchmark of 139 companies, that is well above the median market cap of Rs 142.3 crore and average of Rs 481.12 crore.

Is Fermenta Biotech Ltd. expensive on valuation metrics?

Ans. Fermenta Biotech Ltd. trades at a P/E of 22.95 and P/B of 4.08. Its P/E is above the industry median of 18.11, while its P/B is notably above the industry median of 1.82 in the supplied comparison.

How profitable is Fermenta Biotech Ltd. based on the supplied data?

Ans. Fermenta Biotech Ltd. reports ROE of 4.27 and ROCE of 7.5 in the supplied data. Both are positive, but they are below the same-industry medians of 9.93 for ROE and 12.96 for ROCE.

What do EPS, book value and dividend yield show for Fermenta Biotech Ltd.?

Ans. Fermenta Biotech Ltd. has EPS of 24.38, book value per share of Rs 137.06 and dividend yield of 0.67. These figures show earnings support, accounting net worth behind each share and a modest historical/current payout profile.

How does Fermenta Biotech Ltd. compare with peers?

Ans. Fermenta Biotech Ltd. has a lower P/E than Jagsonpal Pharmaceuticals, Amrutanjan Health Care, Windlas Biotech, Ind-Swift Laboratories and Indoco Remedies. However, its ROE and ROCE are weaker than most of these peers in the supplied dataset.

Which sector and industry does Fermenta Biotech Ltd. belong to?

Ans. Fermenta Biotech Ltd. belongs to the Healthcare sector and Pharmaceuticals & Drugs industry. The supplied benchmark scope is same industry, covering 139 companies, while the broader Healthcare sector snapshot includes 201 companies.

What should investors track next for Fermenta Biotech Ltd. Share Price?

Ans. Investors can track whether Fermenta Biotech Ltd. Share Price continues to hold near its one-year high while monitoring P/E, P/B, ROE, ROCE, market-cap positioning and peer comparisons on Univest for deeper context around valuation and quality.